On November 3, PhRMA sponsored The Atlantic’s People v. Cancer event, hosting “PhRMA Presents: The Future of Fighting Cancer.” PhRMA’s Chief Operating Officer, Lori Reilly, joined Eli Lilly and Company’s Jacob Van Naarden, Chief Executive Officer at Loxo@Lilly, for a conversation on recent advancements in cancer research and care, as well as the potential negative impacts of the Inflation Reduction Act on cancer research and treatment development.

When:

November 3, 2022, at 10:30 a.m. ET

Speakers:

• Lori Reilly, Esq., Chief Operating Officer, PhRMA
• Jacob Van Naarden, Executive Vice President, Eli Lilly and Company; Chief Executive Officer, Loxo@Lilly